Form 4: Tg Therapeutics Director Reports Stock Transaction
Insider Transaction (Form 4)
Laurence N Charney, a Director of Tg Therapeutics, Inc., reported multiple transactions in common stock on August 6, 2026.
Summary
- Bona fide gift: disposed of 5,100 Common Stock on August 6, 2026; holds 174,590 after (Direct).
- Bona fide gift: disposed of 500 Common Stock on August 7, 2026; holds 174,090 after (Direct).
- Bona fide gift: disposed of 450 Common Stock on August 7, 2026; holds 173,640 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Laurence N Charney — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-06 | Bona fide gift | Common Stock | 5,100 | — | — | 174,590 |
| 2026-08-07 | Bona fide gift | Common Stock | 500 | — | — | 174,090 |
| 2026-08-07 | Bona fide gift | Common Stock | 450 | — | — | 173,640 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-06 | Bona fide gift (5,100 shares) |
| 2026-08-07 | Bona fide gift (500 shares) |
| 2026-08-07 | Bona fide gift (450 shares) |
Keywords
insider transaction, Form 4, TGTX, TG THERAPEUTICS, INC., neutral, Laurence N Charney
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.